Comparative study of Potassium Competitive acid blocker (P-CAB) and Classic proton pomp inhibitor in clinical effectiveness for gastro-esophageal reflux symptoms :Randomized Comparative study of venoprazan and esomeprazole
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Vonoprazan (Primary) ; Esomeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 08 Jun 2017 Planned number of patients changed from 30 to 40.
- 20 Mar 2017 Planned End Date changed from 31 Jul 2016 to 31 Jul 2017.
- 13 May 2016 New trial record